Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Hospital Ranking Systems Can Be Misleading for Orthopedic Care: Subject to Misrepresentation That Can Lead to Frustration That May Confuse Patients

September 1, 2020

Hospital Ranking Systems: In the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) this month, a new study investigated five hospital rating systems to assess consistency and agreement among the hospitals deemed “high-performing” and “low-performing” for orthopedic surgery. It revealed that the systems generally rate hospitals based on varied data sources and different methodologies that lack robust formal validation. Thus, they are subject to a misrepresentation that can lead to alienated, frustrated, and confused patients.

“Hospital ranking systems are valuable consumer tools for information on the safety and quality of our nation’s hospitals,” said lead author and Vice-Chair of the Department of Orthopaedics at Northwestern Medicine, David W. Manning, MD, FAAOS. “However, our research found there to be very little consistency between rating systems specific to the orthopedic specialty. In fact, it was more likely that any given hospital would be rated as both ‘high-performing’ and ‘low-performing’ for quality across multiple rating systems than it was for anyone hospital to be ranked as ‘high-performing’ across the board.”

Hospital rating systems are not new. They have become increasingly available to the public and replied upon by patients. Most rating systems base the results on four basic groups of data: structure, process, outcomes, and reputational scores. Reasons for the varied results across rating systems include weighting each of these groups of data differently, opposing data sources and various methodologies for processing the data within each group. Because there is no universally accepted method for measuring or reporting excellence in orthopedic surgery, each rating system is designed to support the missions of the companies that create them. Each has a unique method for data procurement and processing which results in inconsistencies across hospital rating systems.

According to Dr. Manning, with such variability between hospital rating systems, the responsibilities fall to individual institutions and physicians to report their own outcomes with transparency.

“Inconsistency among these rating systems makes it more important for us to own the conversation with our patients by providing patient commentary regarding our own performance and our own internal quality metrics for any given procedure, rather than having the rating systems do that for us,” Dr. Manning added.

For patients seeking specific orthopedic treatment or assistance, Dr. Manning suggests caution when using ranking systems as the be-all-end-all, and shares the following tips to assessing current and future orthopedic care:

  • Don’t rely solely on rating systems
  • Look for hospital and physician self-reported quality metrics and compare to local competitors
  • Ask friends and family for personal experiences and recommendations to validate your findings
  • Refer to your general physician for advice
  • Trust your instincts

The review article notes that further research is needed regarding rating systems that assess not only orthopedic surgery programs but hospitals and providers, as well. There are many aspects of healthcare that are not addressed by these rating systems, and patients should use ratings as a jumping-off point in evaluating orthopedic specialty care.

“In the future, these rating systems can only get better,” Dr. Manning said. “I believe there is a real desire among American healthcare seekers to have quality information about where and from whom they should receive their care. Eventually, there will be an acceptable definition of what constitutes excellent healthcare quality and it will be available to patients to freely review.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy